Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response

Journal of Immunology

Volumn 178, Issue 1, 2007, Pages 539-546

  Liu, Wujiang ^a   Evanoff, David P ^a   Chen, Xiaohong ^a   Luo, Yi ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NERVE GROWTH FACTOR; OVALBUMIN; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BLADDER EPITHELIUM; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYSTITIS; EFFECTOR CELL; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 33845953174     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.1.539     Document Type: Article

References (54)

1. Starr, T. K., S. C. Jameson, and K. A. Hogquist. 2003. Positive and negative selection of T cells. Annu. Rev. Immunol 21: 139-176.
2. Redmond, W. L., and L. A. Sherman. 2005. Peripheral tolerance of CD8 T lymphocytes. Immunity. 22: 275-284.
3. Hanninen, A., E. Hamilton-Williams, and C. Kurts. 2003. Development of new strategies to prevent type 1 diabetes: the role of animal models. Ann. Med. 35: 546-563.
4. Vezys, V., S. Olson, and L. Lefrancois. 2000. Expression of intestine-specific antigen reveals novel pathways of CD8 T cell tolerance induction. Immunity 12: 505-514.
5. Liu, Z., and L. Lefrancois. 2004. Intestinal epithelial antigen induces mucosal CD8 T cell tolerance, activation, and inflammatory response. J. Immunol. 173: 4324-4330.
6. + T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice. J. Invest. Dermatol. 123: 109-115.
7. Lees, J. R., B. Charbonneau, J. D. Hayball, K. Diener, M. Brown, R. Matusik, M. B. Cohen, and T. L. Ratliff. 2005. T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate 66: 578-590.
8. Sheffield, J. S., and F. G. Cunninghan. 2005. Urinary tract infection in women. Obstet. Gynecol. 106: 1085-1092.
9. Palou, J., L. Rodriguez-Villamil, A. Andreu-Crespo, J. Salvador-Bayarri, and J. Vicente-Rodriguez. 2001. Intravesical treatment of severe bacillus Calmette-Guerin cystitis. Int. Urol. Nephrol. 33: 485-489.
10. Ratliff, T. L., C. G. Klutke, M. Hofmeister, F. He, J. H. Russell, and M. J. Becich. 1995. Role of the immune response in interstitial cystitis. Clin. Immunol. Immunopathol 74: 209-216.
11. Peeker, R., L. Atanasiu, and Y. Logadottir. 2003. Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis. Scand. J. Urol. Nephrol. 37: 60-63.
12. van de Merwe, J. P., T. Yamada, and Y. Sakamoto. 2003. Systemic aspects of interstitial cystitis, immunology and linkage with autoimmune disorders. Int. J. Urol. 10(Suppl.): S35-S38.
13. Stone, A. R., K. B. Quattrocchi, C. H. Miller, and J. P. MacDermott. 1991. Role of the immune system in interstitial cystitis. Semin. Urol. 9: 108-114.
14. MacDermott, J. P., C. H. Miller, N. Levy, and A. R. Stone. 1991. Cellular immunity in interstitial cystitis. J. Urol. 145: 274-278.
15. Chai, T. C., and S. Keay. 2004. New theories in interstitial cystitis. Nat. Clin. Pract. Urol. 1: 85-89.
16. Tomaszewski, J. E., J. R. Landis, V. Russack, T. M. Williams, L. P. Wang, C. Hardy, C. Brensinger, Y. L. Matthews, S. T. Abele, J. W. Kusek, and L. M. Nyberg. 2001. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 57: 67-81.
17. Clarke, S. R., M. Barnden, C. Kurts, F. R. Carbone, J. F. Miller, and W. R. Heath. 2000. Characterization of the ovalbumin-specific TCR transgenic line OT-1: MHC elements for positive and negative selection. Immunol. Cell Biol. 78: 110-117.
18. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
19. Lin, J. H., H. Zhao, and T. T. Sun. 1995. A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc. Natl. Acad. Sci. USA 92: 679-683.
20. Kerr, D. E., F. Liang, K. R. Bondioli, H. Zhao, G. Kreibich, R. J. Wall, and T. T. Sun. 1998. The bladder as a bioreactor: urothelium production and secretion of growth hormone into urine. Nat. Biotechnol. 16: 75-79.
21. Zhang, Z. T., J. Pak, E. Shapiro, T. T. Sun, and X. R. Wu. 1999. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res. 59: 3512-3517.
22. Zhang, Z. T., J. Pak, H. Y. Huang, E. Shapiro, T. T. Sun, A. Pellicer, and X. R. Wu. 2001. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene 20: 1973-1980.
23. Cheng, J., H. Huang, Z. T. Zhang, E. Shapiro, A. Pellicer, T. T. Sun, and X. R. Wu. 2002. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res. 62: 4157-4163.
24. Gao, J., H. Y. Huang, J. Pak, J. Cheng, Z. T. Zhang, E. Shapiro, A. Pellicer, T. T. Sun, and X. R. Wu. 2004. p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene 23: 687-696.
25. Salz, W., D. Eisenberg, J. Plescia, D. S. Garlick, R. M. Weiss, X. R. Wu, T. T. Sun, and D. C. Altieri. 2005. A survivin gene signature predicts aggressive tumor behavior. Cancer Res. 65: 3531-3534.
26. Mo, L., J. Cheng, E. Y. Lee, T. T. Sun, and X. R. Wu. Gene deletion in urothelium by specific expression of Cre recombinase. 2005. Am. J. Physiol 289: F562-568.
27. Kim, M. O., S. H. Kim, S. R. Lee, K. S. Kim, K. S. Min, H. T. Lee, S. J. Kim, and Z. Y. Ryoo. 2006. Transgene expression of biological active recombinant human granulocyte-colony stimulating factor (hG-CSF) into mouse urine. Life Sci. 78: 1003-1009.
28. + T cells. Immunology 117: 248-261.
29. Stec, D. E., S. Morimoto, and C. D. Sigmund. 2001. Vectors for high-level expression of cDNAs controlled by tissue-specific promoters in transgenic mice. BioTechniques 31: 256-258.
30. Luo, Y., H. Yamada, X. Chen, A. A. Ryan, D. P. Evanoff, J. A. Triccas, and M. A. O'Donnell. 2004. Recombinant Mycobacterium bovis bacillus Calmette-Guerin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity. Clin. Exp. Immunol. 137: 24-34.
31. Luo, Y., X. Chen, and M. A. O'Donnell. 2003. Role of Th1 and Th2 cytokines in BCG-induced IFN-γ production: cytokine promotion and simulation of BCG effect. Cytokine 21: 17-26.
32. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
33. Winzler, C., P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V. S. Zimmermann, J. Davoust, and P. Ricciardi-Castagnoli. 1997. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 185: 317-328.
34. Nunez, N. P., W. J. Oh, J. Rozenberg, C. Perella, M. Anver, J. C. Barrett, S. N. Perkins, D. Berrigan, J. Moitra, L. Varticovski, et al. 2006. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation. Cancer Res. 66: 5469-5476.
35. Saban, R., M. R. Saban, N. B. Nguyen, T. G. Hammond, and B. K. Wershil. 2001. Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice. Physiol. Genomics 1: 35-43.
36. Siemens, D. R., B. D. Elzey, D. M. Lubaroff, C. Bohlken, R. J, Jensen, A. K. Swanson, and T. L. Ratliff. 2001. Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix. J. Immunol. 166: 731-735.
37. + intestinal intraepithelial lymphocytes are partially but not fully activated T cells. J. Immunol. 169: 4717-4722.
38. + regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J. Autoimmun. 25: 63-71.
39. + T cells in multiple sclerosis and its animal models. Curr. Drug Targets Inflamm. Allergy 4: 239-245.
40. + T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 52: 201-211.
41. + T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35: 76-85.
42. Juedes A, E., E. Rodrigo, L. Togher, L. H. Glimcher, and M. G. von Herrath. 2004. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 199: 1153-1162.
43. + T cells. J. Exp. Med. 186: 239-245.
44. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186: 2057-2062.
45. + T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J. Exp. Med. 188: 415-420.
46. Mayerova, D., E. A. Parke, L. S. Bursch, O. A. Odumade, and K. A. Hogquist. 2004. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity. 21: 391-400.
47. Vezys, V., and L. Lefrancois. 2002. Cutting edge: inflammatory signals drive organ-specific autoimmunity to normally cross-tolerizing endogenous antigen. J. Immunol 169: 6677-6680.
48. Kurts, C., R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. Miller, and W. R. Heath. 1999. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 96: 12703-12707.
49. + T-cell tolerance by cross-presentation of self antigens, Immunol Rev. 165: 267-277.
50. Kurts, C., J. F. Miller, R. M. Subramaniam, F. R. Carbone, and W. R. Heath. 1998. Major histocompatibility complex class I-restricted cross-presentation is biased toward high dose antigens and those released during cellular destruction. J. Exp. Med. 188: 409-414.
51. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol 6: 135-142.
52. Nakae, S., H. Suto, M. Iikura, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. 2006. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J. Immunol 176: 2238-2248.
53. Kurts, C., W. R. Heath, F. R. Carbone, J. Allison, J. F. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184: 923-930.
54. McGargill, M. A., D. Mayerova, H. E. Stefanski, B. Koehn, E. A. Parke, S. C. Jameson, A. Panoskaltsis-Mortari, and K. A. Hogquist. 2002. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J. Immunol. 169: 2141-2147.